Kiromic Biopharma Inc (KRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KRBP | BMY | AMGN | GILD | REGN |
| Company | Kiromic Biopharma Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.7500 | 44.68 | 265.72 | 65.50 | 881.72 |
| High | 3.0800 | 45.37 | 271.68 | 66.35 | 887.48 |
| Low | 2.3775 | 44.34 | 265.72 | 64.63 | 875.23 |
| Last | 3.0800 | 45.17 | 270.32 | 65.59 | 883.42 |
| Change | +0.3700 | +0.47 | +0.94 | +0.32 | -7.26 |
| % Change | +13.65% | +1.05% | +0.35% | +0.49% | -0.82% |
| Volume | 1,450 | 9,101,183 | 676,102 | 7,076,196 | 241,977 |
| 20-Day Average Volume | 4,008 | 12,582,585 | 2,066,926 | 6,773,638 | 443,478 |
| Previous Close | 2.7100 | 44.70 | 269.38 | 65.27 | 890.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.6977 | 49.48 | 269.99 | 68.30 | 918.50 |
| 20-Day Raw Stochastic | 46.91% | 7.68% | 40.81% | 9.84% | 7.49% |
| 20-Day Relative Strength | 48.20% | 30.50% | 45.67% | 29.53% | 32.89% |
| Weighted Alpha | -68.48 | -33.91 | +9.55 | -23.40 | +9.67 |
| Today's Opinion | 64% Buy | 88% Sell | 56% Sell | 100% Sell | 8% Sell |
| Previous Opinion | 80% Buy | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 80% Buy | 8% Buy | 40% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.90% since 04/18/24 | -7.83% since 04/19/24 | +0.46% since 04/19/24 | -1.92% since 04/19/24 | -1.62% since 04/19/24 |
| Low | 2.3775 on 04/26/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 2.9500 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 915.70 on 04/24/24 |
| 1-Month | |||||
| %Chg | -22.53% since 03/26/24 | -14.18% since 03/26/24 | -4.12% since 03/26/24 | -9.58% since 03/26/24 | -8.43% since 03/26/24 |
| Low | 1.7125 on 04/08/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 3.1300 on 04/17/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +58.50% since 01/26/24 | -9.26% since 01/26/24 | -13.35% since 01/26/24 | -17.66% since 01/26/24 | -6.14% since 01/26/24 |
| Low | 1.2500 on 03/14/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 875.22 on 04/26/24 |
| High | 3.7800 on 02/22/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +579.29% since 10/26/23 | -14.86% since 10/26/23 | +0.17% since 10/26/23 | -16.59% since 10/26/23 | +11.40% since 10/26/23 |
| Low | 0.1800 on 12/13/23 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 769.19 on 10/27/23 |
| High | 3.7800 on 02/22/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,491 | 90,596,128 | 144,488,960 | 81,266,176 | 97,762,816 |
| Shares Outstanding, K | 1,288 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -20,950,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -4,690,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 2.00 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -4.16 on 03/18/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/20/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 9.98 | 24.12 |